“Boehringer has had a successful year as one of the leading research investors in the industry. Our impressive pipeline is coming together nicely, with many contributions from clinical trial sites in Australia and New Zealand," said Dirk Otto, the general manager of Boehringer Ingelheim Australia and New Zealand.
'We celebrate our 60th anniversary in Australia, I am extremely optimistic about the next 60'
April 17, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Mark Butler: Patients waiting too long and 'as the Health Minister, of course, I am sorry for that'
March 24, 2025 - - Latest News -
Call for safety net change with half a million Australians missing out on cheaper medicines
March 24, 2025 - - Latest News -
Nanotechnology could improve odds in treating aggressive breast cancers
March 24, 2025 - - Latest News -
Industry pushes back on conspiracy theories, highlighting the Government's own comments
March 22, 2025 - - Latest News -
Medicines Australia announces appointment of new board chair
March 20, 2025 - - Latest News -
The 'Week in Review Dispatched' Podcast - 21 March
March 20, 2025 - - Podcast -
New NZ approval clears the way for expanded access to cystic fibrosis therapy
March 20, 2025 - - Latest News